Immuron reveals anti-Covid potential, raises $28 million

Hot on the heels of reporting anti-Covid-19 action by one of the drugs it is developing, biotechnology company Immuron has raised $28 million (US$20 million) from institutional investors. On Tuesday the company reported its Travelan product for the prevention of travellers’ diarrhoea demonstrated neutralising activity against severe acute respiratory syndrome coronovirus-2, the virus that causes…

Cabinet makers link up with Australian Made

The Australian Made Campaign (AMCL) has welcomed the Australian Cabinet and Furniture Association (ACFA) as an associate to support the continued growth of Australia’s local furnishings and furniture manufacturing sector. NSW-based ACFA is one of Australia’s primary industry associations for furnishing, cabinetmaking and joinery manufacturers, along with the semi-national Australasian Furnishing Association, which is also…